Market Place
Sourcing Support
Novartis Asks Court for Swift Decision in Entresto Patent Case
07 Jun 2025 //
FIERCE PHARMA
Novartis` Pluvicto to Slow Prostate Cancer in Earlier Setting
03 Jun 2025 //
REUTERS
Novartis Kisqali Cut Recurrence Risk in Young Early Breast Cancer
01 Jun 2025 //
GLOBENEWSWIRE
Novartis expands collaboration with Shanghai Pharma in China
27 May 2025 //
FIERCE PHARMA
5 People Accused of Insider Trading Tied to Novartis Buy
27 May 2025 //
FIERCE BIOTECH
Novartis starts tender offer for Regulus Therapeutics
27 May 2025 //
GLOBENEWSWIRE
Apotex Launches Generic Tasigna Capsules in Us with Exclusivity
27 May 2025 //
PR NEWSWIRE
Novartis Offers Payment Plan for High-Cost Heart Medicine
27 May 2025 //
ECONOMICTIMES
Novartis data at ASCO and EHA highlights Momentum of Portfolio
15 May 2025 //
GLOBENEWSWIRE
Abu Dhabi, Novartis Ink Deal for Disease Prevention
14 May 2025 //
BIOSPECTRUM
Erasca looks to partner off late-stage melanoma asset
14 May 2025 //
FIERCE BIOTECH
Novartis to keep making malaria drugs if orders dry up amid cuts
12 May 2025 //
REUTERS
PTC and Novartis’ Huntington`s data fail to convince investors
07 May 2025 //
FIERCE BIOTECH
Incyte, Novartis reach settlement in Jakafi royalty dispute
06 May 2025 //
FIERCE PHARMA
BioNTech says Novartis executive Zapata to become CFO
05 May 2025 //
REUTERS
Novartis to buy Regulus in up to $1.7 Billion deal
01 May 2025 //
REUTERS
Novartis axes osteoarthritis asset and radioligand therapy
29 Apr 2025 //
FIERCE BIOTECH
Novartis builds momentum with new drug launches
29 Apr 2025 //
FIERCE PHARMA
Novartis raises 2025 forecast on strong Q1 momentum
29 Apr 2025 //
REUTERS
Novartis sees double-digit sales growth, margin expansion in Q1
28 Apr 2025 //
GLOBENEWSWIRE
Novartis & Sanofi CEOs say EU should raise drug prices of tariffs
23 Apr 2025 //
REUTERS
Novartis terminates Ph 2 osteoarthritis trial testing
17 Apr 2025 //
FIERCE BIOTECH
Novartis unveils $23B investment to beef up US manufacturing
12 Apr 2025 //
PR NEWSWIRE
Blackstone & Anthos Announce Novartis has Completed Acquisition
03 Apr 2025 //
BUSINESSWIRE
Novartis receives FDA accelerated approval for Vanrafia
03 Apr 2025 //
PR NEWSWIRE
Grove AI Adds Former Executives to Advisory Board
02 Apr 2025 //
GLOBENEWSWIRE
Market volatility halts Novartis` India arm stake sale
01 Apr 2025 //
#N/A
Novartis appoints Karen Hale as Chief Legal Officer; Klaus Moosma
31 Mar 2025 //
GLOBENEWSWIRE
FDA approve Novartis therapy Pluvicto for earlier use in Prostate Cancer
28 Mar 2025 //
GLOBENEWSWIRE
Novartis to present new data at AAN on Kesimpta® safety in MS.
25 Mar 2025 //
GLOBENEWSWIRE
Novartis receives third FDA approval for oral Fabhalta
21 Mar 2025 //
GLOBENEWSWIRE
Novartis’ Intrathecal Zolgensma Effective in Older Children
20 Mar 2025 //
BIOSPACE
Novartis & Roche ditch some diversity programmes on US concerns
20 Mar 2025 //
REUTERS
Novartis Ph 3 Data Shows Efficacy Of onasemnogene abeparvovec In SMA
19 Mar 2025 //
GLOBENEWSWIRE
Novartis is watching US reciprocal tariff policy `very carefully`
17 Mar 2025 //
REUTERS
Novartis and Folia Health Partner on App-Based IgA Nephropathy Study
13 Mar 2025 //
GLOBENEWSWIRE
Novartis named first corporate pharma partner of Football League
13 Mar 2025 //
PR NEWSWIRE
Novartis shareholders approve resolutions at 2025 AGM
07 Mar 2025 //
GLOBENEWSWIRE
Novartis’ Fabhalta Gets Positive CHMP Opinion For C3G
28 Feb 2025 //
GLOBENEWSWIRE
Novartis Presents HS & CSU Data At AAAAI & AAD 2025
28 Feb 2025 //
GLOBENEWSWIRE
HMRI partners with Novartis Australia to supercharge heart health
19 Feb 2025 //
BIOSPECTRUM
Novartis buys Blackstone`s Anthos for up to $3.1 billion
12 Feb 2025 //
REUTERS
Novartis gives up on anti-CD40 antibody to treat Sjögren`s
01 Feb 2025 //
FIERCE BIOTECH
Novartis beats Q4 earnings consensus as drug sales surge
31 Jan 2025 //
REUTERS
Novartis Continues Sales Growth Momentum With Margin Expansion
31 Jan 2025 //
GLOBENEWSWIRE
Novartis handily beats Q4 earnings consensus
31 Jan 2025 //
REUTERS
Novartis runs breast cancer awareness blitz in Super Bowl ad
28 Jan 2025 //
FIERCE PHARMA
Novartis wins 11th-hour bid to block Entresto generic from MSN
17 Jan 2025 //
FIERCE PHARMA
Novartis wins temporary pause to Entresto generic launch in US
16 Jan 2025 //
REUTERS
Novartis Entresto® US patent upheld by US Court of Appeals
13 Jan 2025 //
GLOBENEWSWIRE
Right out of the gate, Light Horse nabs $62M and Novartis deal
10 Jan 2025 //
FIERCE BIOTECH
Novartis`s Fabhalta Receives Approval in Canada
06 Jan 2025 //
HEALTH CANADA
Novartis readies intrathecal Zolgensma for older SMA patients
02 Jan 2025 //
FIERCE PHARMA
Novartis MS Drug Kickback Claims Advance in US Court
31 Dec 2024 //
REUTERS
Novartis Gene Therapy Benefits Kids with Rare Muscle Disorder
31 Dec 2024 //
PRESS RELEASE
Novartis SMA Phase III Study Meets Primary Endpoint
30 Dec 2024 //
GLOBENEWSWIRE
Rapt pays $35M for challenger to Novartis, Roche drug
24 Dec 2024 //
FIERCE BIOTECH
Novartis to close 2 MorphoSys sites, lay off 330 staffers
19 Dec 2024 //
FIERCE PHARMA
Novartis, AbbVie & PhRMA secure 340B court win in West Virginia
19 Dec 2024 //
ENDPTS
Novartis, BioAge take on age-related diseases in $550M pact
19 Dec 2024 //
FIERCE BIOTECH
